POPULARITY
Categories
Last year, Kyle and Nicole Muldoon welcomed their baby KJ into the world. Almost immediately, doctors realized something was wrong. KJ had been born with a genetic mutation that made it impossible to regulate the amount of ammonia in his system. The rare disease had the potential to kill him or cause severe brain damage. But KJ is almost 10 months old today. And he's doing better than ever. Because this little baby has become a piece of medical history: the first patient of any age to receive a personalized gene-editing treatment. It's truly remarkable. In the hundreds of years of modern science, no human being had ever received a medicine designed specifically to correct their genetic mutation. A medicine built for one. That is, until KJ Muldoon. Today, we have a very special guest: Dr. Kiran Musunuru, the gene-editing researcher at the University of Pennsylvania at the center of this breakthrough. We talk about the full story of saving baby KJ, what this breakthrough means for science, and what we need to learn or change to make personalized genetic medicine possible at a larger scale. If you have questions, observations, or ideas for future episodes, email us at PlainEnglish@Spotify.com. Host: Derek Thompson Guest: Dr. Kiran Musunuru Producer: Devon Baroldi Learn more about your ad choices. Visit podcastchoices.com/adchoices
New federal law targets the removal of deepfakes and non-consensual intimate imagery online.Colorado law sparks controversy over parental rights and biblical views on sex and gender.Georgia hospital keeps a brain-dead woman on life support due to state laws.The world's first gene-editing treatment used to heal a one-week-old baby.Join us for ANCHORED: A Conference for Pastors, Church Leaders and the Community June 9-11, 2025. Hosted by Talbot School of Theology at Biola University in Southern California. Learn more and register at https://www.biola.edu/anchored ==========Think Biblically: Conversations on Faith and Culture is a podcast from Talbot School of Theology at Biola University, which offers degrees both online and on campus in Southern California. Find all episodes of Think Biblically at: https://www.biola.edu/think-biblically. Watch video episodes at: https://bit.ly/think-biblically-video. To submit comments, ask questions, or make suggestions on issues you'd like us to cover or guests you'd like us to have on the podcast, email us at thinkbiblically@biola.edu.
Welcome back to Impact Theory with Tom Bilyeu. In this episode, Drew and I take you through a whirlwind week where politics, world affairs, and tech innovation collide. We dissect Biden's shocking cancer diagnosis and what it means for the country, dig into Bernie Sanders' eyebrow-raising admission about the Democratic Party, and go deep on just how broken the government really is—and how (or if) it can ever be fixed. We tackle the big questions: What does it take to create a thriving middle class? Should we trust the government to spend more and do more, or do we need to completely rethink the machine? Are we living through a crisis of vision, where our leaders offer no North Star to inspire the country? And with news breaking on both the NIH's gain-of-function research and China's clampdown on gene editing, are we prepared for the next wave of scientific disruption? SHOWNOTES 00:00 – Biden's Cancer Diagnosis: Personal Impact & Political Fallout 03:14 – Are Our Leaders Too Old? The Real Problem with Political Power 07:08 – Lincoln's Legacy and the Ugly Truth Behind Political Narratives 10:58 – Why America Needs a New Vision (and Why We Don't Have One) 12:59 – Bernie Sanders & the Democratic Party: A Threat to Democracy? 15:39 – Can We Fix the System, or Is It Rigged Beyond Repair? 21:19 – Why Government Spending Is Broken (and How It Could Be Fixed) 27:00 – Positive Visions, Populism, and the Future of American Politics 32:03 – NIH, Wuhan Lab, and the Danger of Silencing Truth Seekers 43:31 – China, Gene Editing, and a New Age of Scientific Heresy 53:02 – Agentic AI: The Next Phase, What It Means, and How to Win 57:56 – Which Jobs Are Disappearing, and Which Will Survive the AI Revolution? 1:02:17 – Business in the Age of Hyper Turnover: What You Need to Know 1:09:36 – Ukraine, Russia, and Trump's Latest Negotiation: A Real Path to Peace? 1:10:13 – The Epstein Files: Government Secrecy and Conspiracy Theories CHECK OUT OUR SPONSORS Vital Proteins: Get 20% off by going to https://www.vitalproteins.com and entering promo code IMPACT at check out Monarch Money: Use code THEORY at https://monarchmoney.com for 50% off your first year! Shopify: Sign up for your one-dollar-per-month trial period at https://shopify.com/impact Netsuite: Download the CFO's Guide to AI and Machine Learning at https://NetSuite.com/THEORY iTrust Capital: Use code IMPACTGO when you sign up and fund your account to get a $100 bonus at https://www.itrustcapital.com/tombilyeu Mint Mobile: If you like your money, Mint Mobile is for you. Shop plans at https://mintmobile.com/impact. DISCLAIMER: Upfront payment of $45 for 3-month 5 gigabyte plan required (equivalent to $15/mo.). New customer offer for first 3 months only, then full-price plan options available. Taxes & fees extra. See MINT MOBILE for details. What's up, everybody? It's Tom Bilyeu here: If you want my help... STARTING a business: join me here at ZERO TO FOUNDER SCALING a business: see if you qualify here. Get my battle-tested strategies and insights delivered weekly to your inbox: sign up here. ********************************************************************** If you're serious about leveling up your life, I urge you to check out my new podcast, Tom Bilyeu's Mindset Playbook —a goldmine of my most impactful episodes on mindset, business, and health. Trust me, your future self will thank you. ********************************************************************** LISTEN TO IMPACT THEORY AD FREE + BONUS EPISODES on APPLE PODCASTS: apple.co/impacttheory ********************************************************************** FOLLOW TOM: Instagram: https://www.instagram.com/tombilyeu/ Tik Tok: https://www.tiktok.com/@tombilyeu?lang=en Twitter: https://twitter.com/tombilyeu YouTube: https://www.youtube.com/@TomBilyeu Learn more about your ad choices. Visit megaphone.fm/adchoices
Doctors in the US have become the first to treat a baby with a customised gene-editing therapy after diagnosing the child with a severe genetic disorder that kills about half of those affected in early infancy. Ian Sample explains to Madeleine Finlay how this new therapy works and how it paves the way for even more complex gene editing techniques. David Liu, a professor at the Broad Institute of MIT and Harvard and the inventor of these therapies, also describes the barriers that could prevent them reaching patients, and how he thinks they can be overcome. Help support our independent journalism at theguardian.com/sciencepod
“A triumph of science, a miracle of medicine” is how researcher Fyodor Urnov describes the gene-editing treatment that saved baby KJ Muldoon's life. Now nine months old, KJ was born with a genetic condition called urea cycle disorder, which is fatal for many infants. Urnov was part of the research team supporting KJ's doctors, he tells us what gene-editing treatments could mean for others born with life-threatening conditions.
A baby just received the first ever customized gene editing treatment…and it could transform healthcare! STORY: https://www.wdjx.com/baby-receives-first-ever-gene-editing-treatment-to-treat-rare-disorder/
Infant with rare, incurable disease is first to successfully receive personalized gene therapy treatment We may finally know what happened to the missing water on Mars Revisiting a famous marshmallow experiment: Children more likely to delay gratification if peer promises to wait as well New Twist on Famous Marshmallow Test: What Happens When You Add a Second Kid? Contact the Show: coolstuffcommute@gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices
Welcome back to Impact Theory with Tom Bilyeu. In this episode, get ready as I pull back the curtain on some of the most important moves happening on the global stage—and give you my unfiltered, no-nonsense take on what they really mean for you and the future. My co-host Drew and I tackle everything from Trump's headline-grabbing Middle East negotiations, to the true impact of $600 billion+ in U.S.-Saudi tech and infrastructure deals, to the double-edged sword of “commerce as a bridge” between clashing cultures. You'll hear why I think Trump's deal-making style is both captivating and dangerous, why trying to impose American values on foreign nations is a recipe for disaster, and how culture and economic incentives really shape the world. We dig deep into the nature of power, the hard limits of nation building, why price controls on prescription drugs are a political move (but not a real solution), and the uncomfortable historical realities behind immigration, assimilation, and global order. If you're looking to flag the lines between progress and peril—or just want to understand the real levers of influence behind today's biggest news—this is an episode you don't want to miss. I'm here to give you the tools to see past the spin, break down the real consequences, and make sense of the chaos so you can win in the world that's coming. SHOWNOTES 00:00 – The most unlikely dinner ever: Flavor Flav, DMC, and comic book legend Rob Liefeld 00:06:03 – Trump's trade wins: $600B+ investment, or PR smoke and mirrors? 00:14:12 – When capitalism becomes “icky”: The dangers of government overreach 00:15:45 – Immigration, identity, and the historic “immigration game” 00:17:28 – Trade, jets, and what motivates Trump as dealmaker-in-chief 00:27:41 – The future of genetic manipulation, AI, and the return of eugenics 00:43:19 – Trump's executive order on drug pricing: political win or bad policy? 01:01:06 – Government, free markets, and why healthcare and student costs spiral 01:24:21 – Immigration, assimilation, and what truly makes a nation strong CHECK OUT OUR SPONSORS ButcherBox: Ready to level up your meals? Go to https://ButcherBox.com/impact to get $20 off your first box and FREE bacon for life with the Bilyeu Box! Vital Proteins: Get 20% off by going to https://www.vitalproteins.com and entering promo code IMPACT at check out Shopify: Sign up for your one-dollar-per-month trial period at https://shopify.com/impact Netsuite: Download the CFO's Guide to AI and Machine Learning at https://NetSuite.com/THEORY iTrust Capital: Use code IMPACTGO when you sign up and fund your account to get a $100 bonus at https://www.itrustcapital.com/tombilyeu Mint Mobile: If you like your money, Mint Mobile is for you. Shop plans at https://mintmobile.com/impact. DISCLAIMER: Upfront payment of $45 for 3-month 5 gigabyte plan required (equivalent to $15/mo.). New customer offer for first 3 months only, then full-price plan options available. Taxes & fees extra. See MINT MOBILE for details. Learn more about your ad choices. Visit megaphone.fm/adchoices
Doctors announced this week that they have treated a newborn baby with a rare genetic disease using the world’s first personalized gene editing therapy. Geoff Bennett discussed the treatment and its potential with Dr. Peter Marks. He oversaw gene therapy treatment and vaccine safety and approval for the FDA before he left in March. PBS News is supported by - https://www.pbs.org/newshour/about/funders
Topics discussed on today's show: National BBQ Day, Booze News, Birthdays, History Quiz, Plastic Birds, Best Career Cities, Starbucks Baristas Walk Off, Gene Editing, WNBA Season, Flag Football Olympics, Smack Your Wife Up, 20 in 25, The Trendmill, Stay Or Go with guest judge Garry Gary Beers: Stryker, New Music Friday, and Apologies.
Inside the groundbreaking gene-editing treatment that's giving new hope to parents, as a team of doctors uses a first-of-its-kind procedure to save a baby's life. Also, a deep dive into "Jaws" as the summer blockbuster celebrates the major milestone of turning 50. Plus, meet the forensic artist who has helped solve a record number of crimes thanks to her drawings.
Doctors announced this week that they have treated a newborn baby with a rare genetic disease using the world’s first personalized gene editing therapy. Geoff Bennett discussed the treatment and its potential with Dr. Peter Marks. He oversaw gene therapy treatment and vaccine safety and approval for the FDA before he left in March. PBS News is supported by - https://www.pbs.org/newshour/about/funders
TikTok will try to force teens to meditate after 10PM, X is once again selling checkmarks to US sanctioned groups, and doctors successfully treated a baby with the first ever personalized gene-editing therapy. It's Friday May 16th and here's a quick look at tech in the news this morning from Engadget. Learn more about your ad choices. Visit podcastchoices.com/adchoices
D&P Highlight: Gene editing...is it a medical miracle? full 601 Thu, 15 May 2025 18:55:00 +0000 WEvE6qUqS26y2fLo9MaEfi6TzQEgiFSL news The Dana & Parks Podcast news D&P Highlight: Gene editing...is it a medical miracle? You wanted it... Now here it is! Listen to each hour of the Dana & Parks Show whenever and wherever you want! © 2025 Audacy, Inc. News False https://player.amperwavepodcasting.com
On this episode of “Raise the Line” we welcome Dr. Sheldon Fields, a trailblazer in the nursing field and the president of the National Black Nurses Association. In a candid conversation, Dr. Fields shares his inspiring journey from the bedside to becoming a prominent figure in nursing, HIV/AIDS prevention and academia and also shares the challenges he faced as a Black man in a predominantly white and female field. "I fell in love with a profession that has not always loved me back," he tells host Kelsey Lafayette. Dr. Fields brings over thirty years of experience as an educator, researcher, clinician, administrator, consultant, health policy specialist, and entrepreneur to his current role at NBNA, and as the inaugural associate dean for equity and inclusion at the College of Nursing at Penn State University, where he also serves as a research professor. Listeners will find Dr. Fields' insights on navigating a career in healthcare particularly valuable, as he stresses the importance of resilience, continuing education, and mentorship. It's a compelling listen for anyone interested in the intersection of health, policy, and social justice.Mentioned in this episode:National Black Nurses Association If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
AP correspondent Haya Panjwani reports on gene editing helping a desperately ill baby.
Welcome back to the second half of this eye-opening discussion with Ben Lamm, CEO of Colossal Biosciences. In Part 2, Tom and Ben dig even deeper, tackling the massive ethical questions and transformative possibilities that arise when humans hold the keys to edit and design life itself. Whether it's confronting the future of embryo screening, germline editing, the potential for designer babies, or the international arms race in biotechnology—no topic is off limits. Ben shares insider stories on Colossal's dire wolf project, explains misconceptions about cloning, and reveals the unexpected hurdles and breakthroughs in the world of synthetic biology. They discuss how these advances can directly impact human longevity, environmental crises like plastic pollution, and even set the stage for building the living cities and ocean habitats of tomorrow. This is a no-holds-barred, jam-packed episode for anyone intrigued by the future of engineering life—and the urgent questions we all must face as the bio-revolution unfolds. SHOWNOTES 33:30 – The Moral and Ethical Responsibility of ‘Playing God' 34:58 – Human Genome Editing, Embryo Selection, and the Coming Revolution in IVF 39:14 – The Personal Side: Ben's Own IVF Journey and Making Hard Choices 44:41 – The Slippery Slope: Intelligence, Disease, and Future Human Potential 51:36 – International Competition: US vs. China in Biotech and Human Enhancement 58:46 – Accelerating Gene Editing: Multiplexing, Cloning, and Animal Selection 1:09:12 – Rewilding and Ecosystem Impact: Fact vs. Jurassic Park Fiction 1:22:42 – The Longevity Escape Velocity and Radical Life Extension 1:44:08 – Innovations for the Planet: Enzymes That Break Down Plastic & Ocean Engineering 1:49:40 – The Future of Synthetic Biology: Designed Environments, Health, and Next-Gen Conservation FOLLOW BEN LAMM Twitter/X: @federallamm LinkedIn: Ben Lamm CHECK OUT OUR SPONSORS ButcherBox: Ready to level up your meals? Go to https://ButcherBox.com/impact to get $20 off your first box and FREE bacon for life with the Bilyeu Box! Vital Proteins: Get 20% off by going to https://www.vitalproteins.com and entering promo code IMPACT at check out Shopify: Sign up for your one-dollar-per-month trial period at https://shopify.com/impact Netsuite: Download the CFO's Guide to AI and Machine Learning at https://NetSuite.com/THEORY iTrust Capital: Use code IMPACTGO when you sign up and fund your account to get a $100 bonus at https://www.itrustcapital.com/tombilyeu Mint Mobile: If you like your money, Mint Mobile is for you. Shop plans at https://mintmobile.com/impact. DISCLAIMER: Upfront payment of $45 for 3-month 5 gigabyte plan required (equivalent to $15/mo.). New customer offer for first 3 months only, then full-price plan options available. Taxes & fees extra. See MINT MOBILE for details. What's up, everybody? It's Tom Bilyeu here: If you want my help... STARTING a business: join me here at ZERO TO FOUNDER SCALING a business: see if you qualify here. Get my battle-tested strategies and insights delivered weekly to your inbox: sign up here. ********************************************************************** If you're serious about leveling up your life, I urge you to check out my new podcast, Tom Bilyeu's Mindset Playbook —a goldmine of my most impactful episodes on mindset, business, and health. Trust me, your future self will thank you. ********************************************************************** LISTEN TO IMPACT THEORY AD FREE + BONUS EPISODES on APPLE PODCASTS: apple.co/impacttheory ********************************************************************** FOLLOW TOM: Instagram: https://www.instagram.com/tombilyeu/ Tik Tok: https://www.tiktok.com/@tombilyeu?lang=en Twitter: https://twitter.com/tombilyeu YouTube: https://www.youtube.com/@TomBilyeu Learn more about your ad choices. Visit megaphone.fm/adchoices
In this thrilling installment of Impact Theory, Tom Bilyeu sits down with Ben Lamm, visionary founder and CEO of Colossal Biosciences, a company on a mission to reverse extinction and rewrite the future of conservation and synthetic biology. Ben and Tom dive deep into the mind-bending world of de-extinction, synthetic gene editing, and how the CRISPR revolution is not only unlocking the secrets of life—but also actively engineering it. In Part 1, get ready for a rollercoaster of concepts as Ben explains the technical magic behind gene editing, DNA synthesis, and multiplex genome editing. From the birth of the woolly mouse to the debated revival of dire wolves, Ben reveals the breakthroughs, challenges, and wild stories behind reviving extinct species. You'll learn how Colossal is using advanced computational biology, AI, and hands-on bioengineering to not only bring animals back but also reshape the future of healthcare, genetics, and ethical decision-making. This is part sci-fi, part practical science, and 100% mind-blowing. SHOWNOTES 00:00 – Kicking Off: The Mysteries of Editing Life 00:14 – Emergence of the CRISPR Revolution 01:31 – What Is DNA Synthesis and Multiplex Editing? 03:47 – The Woolly Mouse: Engineering Traits Across Species 07:54 – Breaking Down the Process: IVF, Screening, and Sequencing 09:24 – Mapping Genotype to Phenotype and Its Challenges 12:10 – Targeting Gene Edits: From Theory to Application in Health and Conservation 17:09 – From Hair Organoids to Building Mammoth Traits in Mice 24:41 – The Quest for a Universal Egg and Overcoming Cellular Barriers 26:17 – Artificial Wombs: The Next Frontier in Conservation and Science 31:12 – Scaling Conservation and Bridging to Human Healthcare FOLLOW BEN LAMM Twitter/X: @federallamm LinkedIn: Ben Lamm CHECK OUT OUR SPONSORS ButcherBox: Ready to level up your meals? Go to https://ButcherBox.com/impact to get $20 off your first box and FREE bacon for life with the Bilyeu Box! Vital Proteins: Get 20% off by going to https://www.vitalproteins.com and entering promo code IMPACT at check out Shopify: Sign up for your one-dollar-per-month trial period at https://shopify.com/impact Netsuite: Download the CFO's Guide to AI and Machine Learning at https://NetSuite.com/THEORY iTrust Capital: Use code IMPACTGO when you sign up and fund your account to get a $100 bonus at https://www.itrustcapital.com/tombilyeu Mint Mobile: If you like your money, Mint Mobile is for you. Shop plans at https://mintmobile.com/impact. DISCLAIMER: Upfront payment of $45 for 3-month 5 gigabyte plan required (equivalent to $15/mo.). New customer offer for first 3 months only, then full-price plan options available. Taxes & fees extra. See MINT MOBILE for details. What's up, everybody? It's Tom Bilyeu here: If you want my help... STARTING a business: join me here at ZERO TO FOUNDER SCALING a business: see if you qualify here. Get my battle-tested strategies and insights delivered weekly to your inbox: sign up here. ********************************************************************** If you're serious about leveling up your life, I urge you to check out my new podcast, Tom Bilyeu's Mindset Playbook —a goldmine of my most impactful episodes on mindset, business, and health. Trust me, your future self will thank you. ********************************************************************** LISTEN TO IMPACT THEORY AD FREE + BONUS EPISODES on APPLE PODCASTS: apple.co/impacttheory ********************************************************************** FOLLOW TOM: Instagram: https://www.instagram.com/tombilyeu/ Tik Tok: https://www.tiktok.com/@tombilyeu?lang=en Twitter: https://twitter.com/tombilyeu YouTube: https://www.youtube.com/@TomBilyeu Learn more about your ad choices. Visit megaphone.fm/adchoices
The Smart 7 is an award winning daily podcast, in association with METRO that gives you everything you need to know in 7 minutes, at 7am, 7 days a week...With over 18 million downloads and consistently charting, including as No. 1 News Podcast on Spotify, we're a trusted source for people every day and the Sunday 7 won a Gold Award as “Best Conversation Starter” in the International Signal Podcast Awards If you're enjoying it, please follow, share, or even post a review, it all helps...Today's episode includes the following guests:Guests Sir David Attenborough - Naturalist, Documentary Maker, Birthday Boy Colin Butfield - Co Director of the new documentary “Ocean” Dr John Siddorn - CEO of the National Oceanography Centre Will Guyatt - The Smart 7's Tech Guru Sean Duffy - US Transport Secretary Pete Buttigieg - former US Transport Secretary Thomas Costello - Assistant Professor of Psychology at American University Paul Temple - Vice Chairman of the Global Farmer Network Baroness Bennett - Former Green Party leader, now in the House of Lords, Brad Smith - Neuralink Volunteer and ALS sufferer Becky Waite - Keeper at Paradise Park Nature Reserve, Cornwall Contact us over @TheSmart7pod or visit www.thesmart7.com or find out more at www.metro.co.uk This episode is presented by Mike Wooller, written by Liam Thompson, researched by Lucie Lewis and produced by Daft Doris. Hosted on Acast. See acast.com/privacy for more information.
In this episode of the Breeder Exchange podcast, host Sam Parish, joined by prominent figures Jack Laurie, Robert Gilchrist, Darryl Stevenson, and Mark McCulley, delves into the landscape of the Angus cattle industry. They discuss the integration of phenotypic and genomic data, global collaboration, and gene editing. The conversation covers how different countries are utilizing genomic data, challenges and opportunities in global breeding data sharing, and the ethical, regulatory, and consumer implications of gene editing. The podcast also touches on the future of the beef industry, particularly for young aspiring entrants. The episode concludes with audience questions on the impact of Australian genetics on the US herd.Chapters: 00:00 Welcome to the Breeder Exchange Live Studio00:19 Introducing the Star-Studded Lineup04:50 Diving into Genomics: Innovations and Applications13:56 Global Collaboration in Breeding Data19:07 Exploring Gene Editing in Beef Genetics22:32 Introduction to the Forum Speaker22:51 FDA Approves Gene Editing in Pork23:08 Consumer and Market Response to Gene Editing23:55 Ethical and Practical Considerations of Gene Editing25:55 Global Perspectives on Gene Editing27:51 Ownership and Intellectual Property in Gene Editing28:26 Impact of Gene Editing on Global Angus Population32:47 Fast Five Questions38:31 Audience Questions and Closing RemarksThe Breeder Exchange Podcast is produced by @breeder_genetics, an Australian bovine semen company. The podcast uncovers the story of sires within the Breeder Genetics program, and talks all things beef. Guests on the podcast include reputable individuals from successful programs globally. Follow us! Facebook: https://www.facebook.com/breederexchangeInstagram: https://www.instagram.com/breederexchange/
We're honored to continue our global tour of medical education today with Professor Katarzyna Taran, MD, PhD, a pioneering interdisciplinary researcher of tumor cell biology, an award winning educator noted for her focus on student engagement, and -- in a first for a Raise the Line guest -- a shooting sports certified coach and referee. As Professor Taran explains to host Michael Carrese, these seemingly disparate professional activities require the same underlying attributes: patience, the ability to overcome barriers, openness and adaptation. She believes those last qualities are especially important for today's medical students to acquire given the accelerated pace of change in healthcare. “They need to be equipped with the ability for critical thinking, to analyze and synthesize, and to search for unconventional solutions.” Professor Taran tries to impart these skills, in addition to the medical and scientific knowledge students must know, through a high level of engagement. “Teaching is relational, so try to be familiar with students' concerns. Talk to them, listen to them and you will become someone they trust.” In this wide-ranging and engaging conversation, Professor Taran also discusses her work as the head of the Laboratory of Isotopic Fractionation in Pathological Processes in Chair of Oncology, the use of neurodidactics in teaching, and the connection between the science of pathology and the future of humans in space. Mentioned in this episode:Medical University of Lodz If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
Got Health Questions or Comments?
Joining us on Well Said is licensed social worker and motivational speaker, Michael Kalberer and director at the Inherited Retinal Disorders Service at The Massachusetts Eye and Ear hospital and Assistant Professor of Ophthalmology at Harvard Medical School, Dr. Jason I. Comander. They will be talking about CRISPR gene editing, a technology that can contribute […]
What if a single number, derived from your DNA, could predict your income, education level or even who you're likely to marry? In his new book “The Social Genome,” Princeton University sociologist Dalton Conley explores the science behind how our genes are shaping our society in ways that are both profound and unsettling.Conley explains how our genes, and the genes of those around us, are influencing our lives in ways we barely understand—from fertility clinics selecting embryos based on genetic traits to the rise of “genetic sorting” in everything from dating to zip codes. He also debunks the idea of nature versus nurture, revealing how deeply intertwined they truly are.Are we heading toward a future of genetically coded inequality? And what policies and conversations are urgently needed to ensure we don't cross the line from science into dystopia?
Alternate Current Radio Presents: BOILER ROOM - Learn to protect yourself from pedatory mass mediaOn this episode, Hesher is joined by Mystical Pharaoh, Ruckus and Bazed Lit Analyzer to discuss all the things that used to only exist in the realms of science fiction, books, magazines, short stories, TV shows and movies, that are now very real and being integrated into our physical and our digital existence. Clones (human & animal) made with the gene editing CRISPIR tech and A.I. modeling, BGI mad scientists hunting for that ‘intelligence essence/gene,' biotech nerds in Texas from a company called Colossus unveil their “De-extinction” project with the re-introduction of Dire Wolves (extinct for over ten thousand years) to modern times, Bezos' latest Blue Origin PR stunts with Katy Perry, Gayle King and others allegedly returning from a brief trip to “space,” RFK Jr's latest publicity junket claiming he wants to look into the sharp increase in Autisim over the last 30 years, the drama between Elon Musk and Ashley St. Clair surronding the birth of their son whom Elon named Romulus, the roll out of the REAL ID program, the UK and their ‘pre-crime' algorithm, BitChute closes its platform to the entire UK due to the 2023 Online Safety Act which disallows freedom of speech and expression on the internet as the international censorship campagin's plot thickens! All this and so much more, on this episode of Boiler Room!Reference Links:Ice Breaker: People are using ChatGPT to turn their pets into humans – and the results are very entertaining (X)Shoutout: Twisted A.I. videos from ‘Voidstomper' (IG)REAL ID Required for U.S. Travelers beginning May 7, 2025 (Defense Travel Management Office)Kristi Noem and Homeland Security's marketing video for REAL ID (Homeland Security)Kristi Noem LARPing as ICE ICE Barbie, another marketing video that fell more than flat with the public (X)Ron Paul and Daniel McAdams on REAL ID (X)Ron Paul on REAL ID just before it passed the House decades ago along with the Patriot Act (X)UK developing algorithmic tool to predict potential killers (digitaltrends)RFK Jr claims he's going to take on the Autisim “epidemic” and that the sharp rise in cases of Autism over the last 30 years, skepticism ensues!HHS Secretary RFK Jr. just held a press conference to respond to the CDC's latest numbers on autism rates in the United States (TGP)FDA Shift Away From Animal Testing Sends Lab Shares Into Freefall (ZH)Attributing His Death to the Use of Remdesivir to Treat COVID-19, a Veteran's Spouse Continues to Search for Answers (TGP)DRAMA: Ashley St. Clair Claims Elon Musk Offered Her $15 Million + $100,000 Per Month, But She Turned It Down (TGP)Katy Perry's cringe performance after exiting the B.O. capsule (X)Katy Perry's ridiculous summary after exiting the Blue Origin capsule (X)Katy Perry mentioned the ‘Hoffman Process' – looks culty to us!Internet is ablaze with scathing and skeptical commentary like this about Blue Origin (X)Some users say it kinda looks like a mannaquin was ‘aboard' the flight (X)Tulsi Gabbard Drops Two Huge Bombshells (ZH)‘Staggering' Number Of IRS Employees To Take Buyout: ‘This Is Enormous' (ZH)Guest Blows Joe Rogan Away With a Terrifying Transhumanism Warning (TGP)Kawasaki's new robotic, horse-like, off-road vehicle (IG)Studio Ghibli (Wiki)Support:Alternate Current Radio websiteSupport BOILER ROOM & ACRPatreon (Join and become a member)Shop BOILER ROOM Merch Store
We like to think of Osmosis from Elsevier as a global community of millions of learners, connected by a desire to serve humanity and an inclination to use a diverse mix of educational resources to help them become excellent healthcare practitioners. On today's episode of Raise the Line, we're going to learn how Osmosis has created an opportunity for hundreds of those students from sixty countries to actually solidify those connections through the Osmosis Health Leadership Initiative (OHLI). Our guide to this effort is Osmosis Community Specialist Alfred Collins, who brings a keen interest in developing tech solutions to power the future of human communication to his work with OHLI.“Technology collapses barriers to communication and to understanding the nuances behind culture, behind global perspectives,” he tells host Lindsey Smith. One example he cites is how OHLI members learn about variations in the way different cultures approach collaboration, an important insight to gain as they head into team-based healthcare environments. OHLI members convene regularly over video sessions to hear from leaders in healthcare and learn about hosting successful on-campus events, among other enriching content. They also have an opportunity to provide feedback on improving the Osmosis learning platform, and this year they're participating in a “hackathon” aimed at improving the future of healthcare. Tune in to find out more about what the OHLI program offers, how to apply, and how Alfred thinks virtual reality and AI technologies will impact the future of community building. Mentioned in this episode:Osmosis Health Leadership Initiative If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
Nate Williams and the team discuss the practice of IVF, Orchid's new genetic testing of embryos, and gene editing. What are your thoughts? Let us know!
19keys.com/tour19keys.com/links19keys.com/ScienceIn this must-watch episode of *High Level Conversations,* we explore the intersection of science, emotions, and leadership with the brilliant molecular biologist, Dr. Raven.
Imagine your doctor could precisely predict your personal risk of disease, diagnose the cause of illness with pinpoint accuracy when it did occur, and develop an effective treatment plan with low side effects the first time, rather than through trial and error. That's the promise of personalized medicine. And it would be a revolution in healthcare. At the heart of this vision is the notion that our genetic differences have a big impact on how each of us responds to disease and treatment. To realize a future of personalized medicine then, we need to understand and investigate just how genetic variations, including mutations, contribute to illness and respond to doctors' attempts to address it. But how can scientists do that efficiently with a human genome that spans about three billion base pairs of DNA across tens of thousands of genes? That's where the work of PhD student Dawn Chen comes in. A student in Harvard's Department of Stem Cell and Regenerative Biology and the Systems, Synthetic, and Quantitative Biology Program, Chen was named a recipient of the 2025 Harold M. Weintraub Graduate Student Award for Outstanding Achievement and Exceptional Research in the Biological Sciences, presented by Seattle's Fred Hutch Cancer Center. With her colleagues in the lab of Harvard professor Fei Chen, Dawn Chen is developing an innovative gene-editing tool known as helicase-assisted continuous editing, or HACE. A breakthrough in genetic engineering, supported in part by funds from the National Institutes of Health, HACE makes edits to specific genes, allowing researchers to investigate how genetic variations contribute to disease. The technique could lead to the identification of specific mutations that influence the effectiveness of drugs and therapies for illnesses like cancer.
David Game remembers the days when the use of digital technology in education publishing amounted to putting a dictionary on a compact disc. Now, as the senior vice president of Product Management, Global Medical Education at Elsevier, he oversees a suite of learning materials that use artificial intelligence, virtual reality and 3-D modeling. “We've expanded into immersive technology with Apple Vision Pro that enables you to be inside the human body, to see and explore the human heart from the inside out and it is absolutely stunning,” says Game, whose long career in publishing includes experience in North America, the United Kingdom, Europe, China and India. As Game has witnessed first-hand, advancements in ed tech, including distance learning, have provided students with an array of options and modalities to choose from that accommodate different learning styles and life circumstances, and that puts a premium on being able to meet students where they are. “We want to make sure that students find learning from our materials engaging, efficient, and aligned with how they live their lives and do their work.” Join host Lindsey Smith for this fascinating episode of Raise the Line to learn how Elsevier is leveraging the innovations offered by Osmosis, Complete Anatomy and ClinicalKey Student to enrich the learning of medical students on their journey to becoming excellent clinicians.Mentioned in this Episode:Complete AnatomyClinicalKey StudentOsmosis If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
Michael Petersen has over 38 years of experience as a researcher and mentor in both the private and public plant biotech space. He has over 50 issued patents and his work in plant transformation and gene expression is a passion. Mike has worked on many genetic engineering/editing contracts with entities across the globe, and he now focuses on innovative hemp research. At CannMed 25, Mike will share his team's latest efforts to transform cannabis and hemp plants using gene editing and genetic engineering in a presentation titled, “Creation of Novel Traits Through Genetic Engineering and Editing of Cannabinoid, Terpene, and Flavonoid Pathways in Cannabis sativa” During the conversation, we discussed: The difference between gene editing and genetic engineering How gene editing and genetic engineering methods have changed over the years Potential applications of gene editing and genetic engineering in cannabis and hemp Benefits and challenges versus traditional breeding The Wisconsin Crop Innovation Center's gene editing service, which is available to researchers and cultivators Thanks to This Episode's Sponsor: Kannapedia.net Kanapedia.net is the world's most comprehensive cannabis genomic library, featuring more than 2,200 genomic reports on cannabis and hemp varieties from around the globe. Kannapedia.net reports are easily searchable and contain Visualizations and Variant Tables that highlight high-impact variants in genes of interest. For example, you can see a report for the Badger G variety that Mike Petersen's team edited to break the CBDA synthase gene. In fact, you can see the drop out in the CBDA coverage chart on that report. . Visit Kannapedia.net to learn more. Additional Resources Wisconsin Crop Innovation Center Email Mike Michael Petersen on Linkedin Register for CannMed 25 Meet the CannMed 25 Speakers and Poster Presenters Review the Podcast CannMed Archive
Gene editing in plants – it's been heralded as the next step-function change in the advancement of agriculture. One Indiana company is advancing the technology fresh off a $144 million venture capital raise. Claudia Nari, Chief Product Officer of Inari, joins today to talk through this historic time for gene editing and biotechnology at large. They get into: From speed to precision, Claudia lays out the differentiation of gene editing to other types of plant breeding Crops of focus for Inari right now and stresses they're focused on to enable farmer success The company's recent venture capital raise, their value proposition and educating investors Inari's unique advantage (knowing what to do, having the tools to do it and being able to do those at the same time) The status of field trials and what commercialization will look like for Inari Biggest problems in-field to be solved through gene editing – from yield to resource efficiencies Regulatory hurdles and Claudia's perspective on the acceptance of gene editing as a technology When will Inari technology be in customer fields? And what's next?
Gene editing in plants – it's been heralded as the next step-function change in the advancement of agriculture. One Indiana company is advancing the technology fresh off a $144 million venture capital raise. Claudia Nari, Chief Product Officer of Inari, joins today to talk through this historic time for gene editing and biotechnology at large. They get into: From speed to precision, Claudia lays out the differentiation of gene editing to other types of plant breeding Crops of focus for Inari right now and stresses they're focused on to enable farmer success The company's recent venture capital raise, their value proposition and educating investors Inari's unique advantage (knowing what to do, having the tools to do it and being able to do those at the same time) The status of field trials and what commercialization will look like for Inari Biggest problems in-field to be solved through gene editing – from yield to resource efficiencies Regulatory hurdles and Claudia's perspective on the acceptance of gene editing as a technology When will Inari technology be in customer fields? And what's next?
Dr. Eric Kmiec is Director of the Gene Editing Institute of the Helen F. Graham Cancer and Research Institute at Christiana Care Health System. He also holds faculty appointments at the University of Delaware and the Wistar Institute. Eric and his colleagues are working to develop new ways to treat cancer by destroying the genes that cause cancer cells to be resistant to typical therapies like chemotherapy, radiation, or immunotherapy. Throughout his life, Eric has enjoyed sports. He particularly likes playing baseball and hockey, and he still plays baseball competitively in a league in Philadelphia. Eric also spends much of his time doing landscaping and yard work. He Received his B.A. in Microbiology from Rutgers University, his M.S. in Cell Biology and Biochemistry from Southern Illinois University, and his Ph.D. in Molecular Biology and Biochemistry from the University of Florida School of Medicine. He conducted postdoctoral research at the University of Rochester before joining the faculty at the University of California, Davis in 1987. Since then, he has served on the faculty of Thomas Jefferson University, the University of Delaware, and Delaware State University. In addition, Eric founded, consulted for, and served as Vice President of Kimeragen, Inc., he was Chief Scientific Advisor for the Genomics Division of Tapestry Pharmaceuticals, was an Eminent Scholar and Director of the Marshall University Institute for Interdisciplinary Research, and also served as Co-Founder, Chief Scientific Officer, and a Board Member of OrphageniX. Eric has received numerous awards and honors over the course of his career, including receipt of the 2012 Proudford Foundation Unsung Hero Award in Sickle Cell Disease, designation as an Honorary Commander of the 436th Air Wing at Dover Air Force Base in 2013 and 2014, and also induction into the Southern Illinois University, Edwardsville Alumni Hall of Fame in 2012. Further, Eric and the team at the Gene Editing Institute were recently awarded the inaugural Life Sciences and Bio Innovation Award from the Philadelphia-Israeli Chamber of Commerce. In our interview, Eric shared his experiences in life and science.
An interesting new study from the Geisinger health system in Pennsylvania examining if genomic screening in a large population increases the identification of disease risk prompted Raise the Line to re-release a previous episode about a textbook designed to help all medical providers understand the clinical applications of genomic testing. Genomics in the Clinic: A Practical Guide to Genetic Testing, Evaluation, and Counseling from Elsevier Science Direct dives into the use of this important tool in diagnosis and screening, indicating how individuals may respond to drug therapies, and more. “We really need to educate all healthcare providers about the practice of genetics because they're going to be involved directly or indirectly in genetic testing and conveying information about what the results mean to patients and their families,” explains co-author Dr. Ethylin Wang Jabs, enterprise chair of the Department of Clinical Genomics for Mayo Clinic. Jabs and her co-author, Dr. Antonie Kline, director of Clinical Genetics at the Harvey Institute for Human Genetics at Greater Baltimore Medical Center, chose a format that makes heavy use of case studies to help readers get a better grasp on this complicated field and they also include chapters on direct-to-consumer testing and the ethical and social implications in genomic medicine. “Any kind of potentially predictive testing can have ethical issues related to it, including insurance coverage, testing for family members, protections for minors, and more,” says Dr. Kline. Join host Caleb Furnas for an illuminating episode on an area of discussion in medicine that's growing in importance as the use of genetic testing rapidly increases. Mentioned in this episode: Genomics in the Clinic: A Practical Guide If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
The majority of rare health disorders are genetic in origin but now a treatment using gene editing could be providing a solution for a rare swelling disorder
On this edition of the Naked Scientists Podcast, what are the potential environmental impacts of the ship crash in the North Sea? Also, we find out what's being done to reduce the risk from engineered pandemics, and reveal what's going on inside the best electric vehicle batteries on the market. Then, it's off to Lincolnshire to profile the bruise-resistant, quicker-cooking potatoes of the future... Like this podcast? Please help us by supporting the Naked Scientists
In this edition of Naked Genetics, we take a closer look at CRISPR gene editing. What is it? And what are the ethics involved in rewriting the human genome? Like this podcast? Please help us by supporting the Naked Scientists
In this edition of The Naked Scientists, we take a closer look at CRISPR gene editing. What is it? And what are the ethics involved in rewriting the human genome? Like this podcast? Please help us by supporting the Naked Scientists
Gene Editing in Agriculture, Part 1 Gene Editing in Agriculture, Part 2 New Dairy Product 00:01:05 – Gene Editing in Agriculture, Part 1: Starting today's show is Alison Van Eenennaam, a U.C. Davis professor of cooperative extension who was a speaker at K-State Cattlemen's Day. Alison talks about genetic modification, genetic engineering and gene editing and what has been done so far in the industry and where we could be going. 00:12:05 – Gene Editing in Agriculture, Part 2: Alison continues the show with her conversation about genetic modification, genetic engineering and gene editing in her second segment. Alison Van Eenennaam Animal Biotechnology at U.C. Davis 00:23:05 – New Dairy Product: K-State dairy specialist Mike Brouk ends the show looking at a new product from Dairy Farmers of America that contains less sugar than regular milk and 9 grams of crude protein. The goal is to increase consumption of fluid milk and offer a healthy alternative to plant-based beverages. Send comments, questions or requests for copies of past programs to ksrenews@ksu.edu. Agriculture Today is a daily program featuring Kansas State University agricultural specialists and other experts examining ag issues facing Kansas and the nation. It is hosted by Shelby Varner and distributed to radio stations throughout Kansas and as a daily podcast. K‑State Research and Extension is a short name for the Kansas State University Agricultural Experiment Station and Cooperative Extension Service, a program designed to generate and distribute useful knowledge for the well‑being of Kansans. Supported by county, state, federal and private funds, the program has county Extension offices, experiment fields, area Extension offices and regional research centers statewide. Its headquarters is on the K‑State campus in Manhattan
Today I'm speaking with Liz Parrish, the founder and CEO of BioViva, on the Longevity Optimization Podcast. In this episode, we explore groundbreaking advancements in gene therapy and its potential to cure age-related diseases. Liz shares her personal journey that led to the creation of BioViva, providing insights into the mechanisms of gene therapy and the current landscape of approved therapies. Our conversation delves into the hallmarks of aging, the role of specific genes like follistatin and telomerase, and the future of gene therapy as a preventative measure for health optimization.Liz Parrish is a pioneering figure in the field of gene therapy, dedicated to advancing the science of longevity and health optimization. Throughout our discussion, she addresses the ethical considerations surrounding gene editing and the implications for future generations. We also discuss the significance of gene therapy in combating aging, the role of telomeres in longevity, and the misconceptions about telomerase and cancer. Additionally, Liz explores the potential benefits of hyperbaric oxygen therapy and shares her personal experiences with gene therapy. The conversation touches on skincare, the philosophy of longevity, and the empowerment of women through advancements in gene therapy, highlighting the transformative potential of these innovations for future health.Let's be friends!Instagram: https://www.instagram.com/kaylabarnes/?hl=enTikTok: https://www.tiktok.com/@femalelongevityX: https://x.com/femalelongevityWebsite: https://kaylabarnes.comJoin Female Longevity Community: https://kayla-barnes-lentz.circle.so/checkout/become-a-member Follow Liz ParrishFollow Her on IG: https://www.instagram.com/lizlparrish/Timestamps00:00 Introduction to Gene Therapy and Longevity03:10 The Birth of BioViva and Personal Motivation06:05 Advancements in Gene Therapy and Regenerative Medicine08:49 Understanding Gene Therapy: Mechanisms and Applications11:56 Current Approved Gene Therapies and Their Impact15:08 Exploring the Hallmarks of Aging17:54 The Role of Folistatin and Telomerase in Aging21:04 Preventative Medicine and Gene Therapy24:02 Future of Gene Therapy and Embryo Editing27:08 The Ethics of Gene Editing and Parental Choices29:54 Preparing for a Multi-Planetary Future39:40 Exploring the Future of Space Travel40:08 The Importance of Safe Space Habitation41:06 Gene Therapy and Aging: A Deeper Dive42:52 Telomeres and Their Role in Longevity46:00 Cancer and Telomerase: Debunking Myths47:55 Hyperbaric Oxygen Therapy: Potential Benefits51:11 Balancing Regeneration and Cellular Division53:26 Pioneering Gene Therapy: A Personal Journey58:27 Measuring the Impact of Gene Therapy01:03:11 Skincare and Longevity: A Personal Approach01:10:24 Philosophy of Longevity: Balancing Life and Health01:14:05 Empowerment Through Gene Therapy for Women
To mark International Rare Disease Day, we're going to introduce you to a remarkable young woman, Zainab Alani, who is not letting her challenging rare condition stand in the way of her dream of becoming a physician. After noticing Zainab's struggles with muscle weakness and fatigue at age 15, her mother – a physician – took her to doctors advocating for a diagnosis of the rare autoimmune condition generalized myasthenia gravis (MG). Unfortunately, a series of clinicians attributed her symptoms to her menstrual cycle and other errant causes and even accused Zainab of being ‘a lazy teenager.' “Despite having that support and knowledge behind me, these doctors were dismissing my symptoms because of that deceiving label of rare,” Zainab explains to host Lindsey Smith. Wanting to spare others from this frustrating diagnostic odyssey, Zainab turned to advocacy once in medical school and is working with her sister and others through the organization Rare Aware Glasgow to raise awareness among the general public about rare conditions and to spur the medical community to adjust its perspective. “We don't expect medical professionals to know every single rare disease, we just want them to acknowledge their existence and not dismiss them when a family member or a patient brings them up as a differential diagnosis.” In this inspiring episode in our Year of the Zebra podcast series you'll also learn about intersectionality creating burdens in medical diagnosis and a questionable basis for patients being denied access to new treatments.Mentioned in this episode:Rare Aware GlasgowThe Myasthenia Medic If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
An overdue check-in conversation with Dan Barber, chef, co-owner of Blue Hill restaurants and co-founder of Row 7 Seeds, where we dive into the fascinating world of seeds and how breeding is evolving with the explosion of AI and other technologies. No, we don't need GMOs, CRISPR, or other risky blunt instruments. We discuss the implosion of the fake meat hype, which was at its peak when we last spoke four years ago, why insane umami flavor and potentially self-nitrogen-fixing tomatoes are revolutionary. This is a deep conversation about bread and wheat—and why breeding wheat specifically for whole meal flour is so important, where Row 7 Seeds, his seed company, is headed and why they're launching a CPG brand using pressure-cooked vegetables (because processing isn't a dirty word). When your vegetables come from incredible seeds and are grown in healthy soils, you don't need unhealthy additives. We kick things off with mouthwatering winter spinach and dive into a long conversation about the role of technology in food and agriculture. No, we shouldn't go back to the past. No, we're not Luddites. In fact, Dan is incredibly bullish on the role of AI in natural breeding—perhaps the best of both worlds, enabling faster breeding for local conditions rather than global crops that lack flavor, nutrients, and rely on excessive chemicals.Get ready for a firehose of stories on food, seeds, soil, and culture!More about this episode on https://investinginregenerativeagriculture.com/dan-barber-2.==========================In Investing in Regenerative Agriculture and Food podcast show we talk to the pioneers in the regenerative food and agriculture space to learn more on how to put our money to work to regenerate soil, people, local communities and ecosystems while making an appropriate and fair return. Hosted by Koen van Seijen.==========================
Dr. Kyle Cromer is an Assistant Professor in the Department of Surgery at the University of California, San Francisco School of Medicine. In his lab, Kyle takes gene editing a step further beyond just modifying “the typos” in DNA to correct them back to what the code should be. He uses genome-editing approaches to introduce new functions into cells for different therapeutic purposes. Kyle has always been interested in visual art, so he enjoys visiting art museums and has dabbled in creating his own art as well. He and his wife have been stretching their own canvases and creating their own abstract paintings, each meticulously planned and sketched out in advance. Most recently, the two of them have been immersed in preparations for the birth of their first child. He completed his BS in Animal & Poultry Sciences at Virginia Tech and his PhD in Genetics at Yale University. Afterwards, he conducted postdoctoral research in Genetics at Harvard Medical School. Next he worked as a postdoctoral fellow and subsequently an instructor in Pediatrics at Stanford University before joining the faculty at UCSF. He has received various awards and honors over the past several years, including the Stanford Bio-X Star Mentor Award, the American Society of Gene & Cell Therapy Career Development Award, the UCSF Program for Breakthrough Biomedical Research New Frontier Research Award, the American Society of Hematology Junior Faculty Scholar Award, the Mary Anne Koda-Kimble Seed Award for Innovation from the UCSF School of Pharmacy, and the Catalyst Award from UCSF Innovation Ventures. In this episode, Kyle shares more about his life and science.
Having the ability to manage uncertainty is helpful in all professions, but perhaps especially so in medicine where uncertainty abounds and the stakes for managing it are high. Despite that, medical students receive little training in this area, something which our guest today, Dr. Jenny Moffett of RCSI University of Medicine and Health Sciences in Dublin, is working to change. “There are approaches to uncertainty that can be learned. We can change our perspective and perceptions around uncertainty, stepping away from always viewing it as something aversive, but perhaps maybe looking at it with a little bit more curiosity and openness, and that's definitely a transformation that faculty can make,” says Dr. Moffett, the program director of the Postgraduate Diploma in Health Professions Education. In addition to a perspective shift, Moffett also believes providers should develop skills to talk about uncertainty with patients in an open and honest way. “Clinicians can say, I'm on this journey with you. I don't have all of the answers, but we have paths, we have options, and I'll be there with you as we work them out.” Join host Caleb Furnas as he explores Dr. Moffett's fascinating work in this area which includes development of an immersive puzzle game that encourages students to address complex, ambiguous, and unpredictable issues.Mentioned in this episode:RCSI University of Medicine and Health Sciences If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
CRISPR gene editing is transforming medicine, agriculture, and ethics. Dom Bettinelli, Thomas Sanjurjo, and Jack Baruzzini break down its breakthroughs, risks, and moral questions. Could it cure diseases or lead to designer babies? The future is here! The post CRISPR Gene Editing: Medical Miracle or Pandora's Box? appeared first on StarQuest Media.
The Role of Clinicians in Addressing Climate Change: Dr. Catharina Giudice, Climate and Human Health Fellow, Harvard T.H. Chan School of Public Health “The healthcare system is in this interesting intersection when it comes to its roles and responsibilities as it pertains to climate change,” says our Raise the Line guest Dr. Catharina Giudice, a research fellow in climate and human health at Harvard University. As she explains to host Hillary Acer, the medical industry is a major producer of the greenhouse gasses that are contributing to serious health impacts on patients, especially those who are already vulnerable due to pre-existing conditions and economic struggles. Giudice, whose academic work focuses on healthcare sector climate preparedness, believes this paradox requires a response from clinicians. “There's so many small things that you can do as an individual clinician to make a difference in the climate change intersection.” Options include working to change hospital practices, educating peers and patients on the health impacts of climate change, and advocacy in the public policy arena. In this thought-provoking installment in our NextGen Journeys series, you'll also learn how the healthcare delivery system is being affected by climate change, and about a new concentration in climate change and planetary health at the Harvard T.H. Chan School of Public Health.Mentioned in this episode:Harvard T.H. Chan School of Public HealthHarvard University Center for the EnvironmentPractice Greenhealth If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
We continue our NextGen Journeys series today featuring fresh perspectives on education, medicine, and the future of health care with an impressive medical student who was brought to our attention by a previous podcast guest, Dr. Michael Foti, whom we'd like to thank for the recommendation. Nikolas Bletnitsky is in his third year at Touro College of Osteopathic Medicine, Middletown, but that's just one element in his medical education. Over the last several years, Nick has done extensive work in the field of OB-GYN -- completing clinical electives in Paris, France and Bologna, Italy, in addition to the Mayo Clinic -- where he has pursued his intense interest in a variety of subspecialties, including maternal fetal medicine. “Right now I'm doing a lot because I'm young and I have the energy and I want to see a lot to give me different perspectives on things so that I can incorporate them into my own practice,” he tells host Michael Carrese. Join us for a wide-ranging conversation in which you'll learn about current practice in OB-GYN in the US and Europe, neonatal palliative care and advances in fetal surgery, along with what Nick has learned about having crucial conversations with the parents of patients when tough news needs to be discussed.Mentioned in this episode: Touro College of Osteopathic Medicine, If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
From criminal cases to designer babies, DNA is reshaping humanity's future. Michael Regilio unravels this double helix of discovery on Skeptical Sunday! Welcome to Skeptical Sunday, a special edition of The Jordan Harbinger Show where Jordan and a guest break down a topic that you may have never thought about, open things up, and debunk common misconceptions. This time around, we’re joined by skeptic, comedian, and podcaster Michael Regilio! On This Week's Skeptical Sunday, We Discuss: DNA is simultaneously microscopic and massive in scale — while coiled up tightly in each cell's nucleus, if you unraveled all the DNA in a single human body and laid it end-to-end, it would stretch to the sun not once, but 600 times! This mind-bending fact perfectly illustrates how we're all walking around with an astronomical amount of genetic information packed into our cells. The ethical implications of DNA databases are more complex than a double helix — even if you never take a genetic test yourself, your relatives' DNA decisions can expose your genetic information. It's like playing genetic poker where someone else can accidentally show your hand. This raises serious concerns about privacy, insurance discrimination, and how genetic information could be weaponized by bad actors. CRISPR technology has opened Pandora's genetic toolbox — while it offers incredible potential for treating diseases like sickle cell anemia, it also enables the possibility of "designer babies" and genetic enhancements that could create new forms of social inequality. We're essentially writing code for humans now, but without a clear user manual for the consequences. DNA evidence has revolutionized criminal justice — but it took decades to establish proper standards and protocols. From its first use in catching Colin Pitchfork (whose villainous name seems almost too on-the-nose) to modern genetic genealogy solving cold cases, DNA has become the ultimate witness that never forgets and never lies. Understanding and working with DNA is becoming increasingly accessible and beneficial — from personalized medicine to ancestry exploration to crop improvements, we all have opportunities to engage with and benefit from DNA science. By staying informed about genetic advances while thoughtfully considering their implications, we can help shape a future where this powerful technology serves humanity's best interests rather than our darker impulses. Connect with Jordan on Twitter, Instagram, and YouTube. If you have something you'd like us to tackle here on Skeptical Sunday, drop Jordan a line at jordan@jordanharbinger.com and let him know! Connect with Michael Regilio at Twitter, Instagram, and
What happens when nearly 60 years of combined biohacking expertise collide in one podcast? Peter Diamandis is a world-renowned futurist, space entrepreneur, and innovator behind groundbreaking ventures like the XPRIZE and Abundance 360. Dave sits down with Peter to combine their nearly 60 years of biohacking expertise, delivering the ultimate playbook for living longer and healthier.They dive into revolutionary AI-driven health solutions, mindset shifts that fuel vitality, and practical routines you can start today. Peter, the author of The Longevity Guidebook, shares deeply meaningful tools and tips to expand your healthspan for decades to come. What You'll Learn: • The top AI tools reshaping health and longevity • Simple daily habits that improve energy, sleep, and brain performance • Why mindset is the key to adding years to your life • The cutting-edge science of age reversal and functional health • How Peter and Dave biohack their routines for peak performance Resources: • 2025 Biohacking Conference: https://biohackingconference.com/2025 • Peter Diamandis's New Book: https://longevityguidebook.com/home-blk-nav • Peter Diamandis's Website: https://www.diamandis.com/ • Peter Diamandis's Purpose Finder (MTP): https://purposefinder.ai/ • Danger Coffee: https://dangercoffee.com • Dave Asprey's Website: https://daveasprey.com • Dave Asprey's Book – Smarter Not Harder: https://daveasprey.com/books • Dave Asprey's Linktree: https://linktr.ee/daveasprey • Upgrade Collective – Join The Human Upgrade Podcast Live: https://www.ourupgradecollective.com • Own an Upgrade Labs: https://ownanupgradelabs.com • Upgrade Labs: https://upgradelabs.com • 40 Years of Zen – Neurofeedback Training for Advanced Cognitive Enhancement: https://40yearsofzen.com SPONSORS: -Omni-Biotic | Visit omnibioticlife.com/dave and use code DAVE20 for 20% off. -LMNT | Free LMNT Sample Pack with any drink mix purchase by going to drinklmnt.com/dave. Timestamps: • 00:00 Open • 00:53 Introduction to Peter Diamandis • 01:54 Peter's Longevity Journey • 03:26 Tracking Sleep and Biohacking • 05:49 The Importance of Deep Sleep • 07:22 Thinking Big and Longevity • 10:36 Russian Innovations in Sleep • 25:29 AI and Longevity • 29:01 Gene Editing and Epigenetics • 35:13 Light Therapy and Routines • 43:07 Gut Health and Endotoxins • 44:17 Exploring Conscious Pain Practices • 45:51 Hacking Hot Tubs for Health Benefits • 46:28 The Science Behind Dopamine Reset • 46:43 Introduction to Fountain Life • 48:41 Advanced Diagnostics and AI Integration • 50:29 Therapeutics and Cutting-Edge Treatments • 51:41 The Evolution of Longevity Companies • 55:30 The Future of Longevity and Healthspan • 01:01:27 The Role of AI in Health and Longevity • 01:07:31 Personal Longevity Practices and Insights • 01:16:43 Finding Your Purpose for Longevity • 01:24:01 Final Thoughts and Resources See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.